-
Cisplatin/Carboplatin Plus Etoposide Yield Similar Real-World Efficacy in ES-SCLC
17 Sep 2025 01:13 GMT
… . Presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer …
-
New ROS1+ Lung Cancer Drug Shows Positive Results for Over Half of Patients
16 Sep 2025 21:44 GMT
… oral presentation at the International Association for the Study of Lung Cancer's (IASLC) 2025 …
-
Osimertinib Plus Chemo Significantly Extends Survival for Patients With Lung Cancer
16 Sep 2025 16:39 GMT
… were presented at the International Association for the Study of Lung Cancer's 2025 World …
-
<![CDATA[Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer]]>
15 Sep 2025 23:10 GMT
… Cancer hosted by the International Association for the Study of Lung Cancer.
In a press release …
-
Tarlatamab Combination Regimen Demonstrates Potential as Maintenance Therapy in ES-SCLC
15 Sep 2025 16:36 GMT
… findings presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference … -SCLC.”1
REFERENCES
1. International Association for the Study of Lung Cancer. Tarlatamab with Anti-PD …
-
Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC
15 Sep 2025 16:25 GMT
… survival. Presented at: International Association for the Study of Lung Cancer 2025 World Conference on Lung … NSCLC. Press release. International Association for the Study of Lung Cancer 2025 World Conference on Lung …
-
<![CDATA[Tarlatamab Plus Anti–PD-L1 Therapy as Frontline Maintenance Shows Unprecedented OS in ES-SCLC]]>
15 Sep 2025 15:14 GMT
… were presented during the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference … survival News release. International Association for the Study of Lung Cancer 2025 World Conference on Lung …
-
<![CDATA[Tarlatamab Plus Anti–PD-L1 as Frontline Maintenance Shows Unprecedented OS in ES-SCLC]]>
15 Sep 2025 15:14 GMT
… during the International Association for the Study of Lung Cancer 2025 World … Presented at: International Association for the Study of Lung Cancer 2025 World Conference … release. International Association for the Study of Lung Cancer 2025 World Conference …
-
Lurbinectedin Yields Responses in Various ES-SCLC Subgroups
14 Sep 2025 18:24 GMT
… . Presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer …
-
Real-World Study Finds Benefit of Lutathera in Patients With Lung NETs
14 Sep 2025 14:10 GMT
… dotatate. Presented at: International Association for the Study of Lung Cancer 2025 World Conference on Lung …